Indaptus Therapeutics, Inc. Quarterly Assets in USD from Q4 2020 to Q3 2024

Taxonomy & unit: us-gaap: USD
Description: Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.
Summary: Indaptus Therapeutics, Inc. quarterly Assets history and growth rate from Q4 2020 to Q3 2024.
Indaptus Therapeutics, Inc. Assets for the quarter ending September 30, 2024 was $8.24M, a 53.7% decline year-over-year.

Assets, Quarterly (USD)

Assets, YoY Quarterly Growth (%)

Period	Value	YoY Chg	Change %	Date	Report	Filed
Q3 2024	$8.24M	-$9.55M	-53.7%	Sep 30, 2024	10-Q	2024-11-12
Q2 2024	$8.12M	-$12.7M	-61%	Jun 30, 2024	10-Q	2024-08-12
Q1 2024	$10.9M	-$12.2M	-52.7%	Mar 31, 2024	10-Q	2024-05-08
Q4 2023	$14.9M	-$13.1M	-46.8%	Dec 31, 2023	10-Q	2024-11-12
Q3 2023	$17.8M	-$12.7M	-41.6%	Sep 30, 2023	10-Q	2023-11-06
Q2 2023	$20.8M	-$13.2M	-38.8%	Jun 30, 2023	10-Q	2023-08-14
Q1 2023	$23.1M	-$13.9M	-37.6%	Mar 31, 2023	10-Q	2023-05-11
Q4 2022	$28.1M	-$12.5M	-30.8%	Dec 31, 2022	10-K	2024-03-13
Q3 2022	$30.5M	-$13.4M	-30.6%	Sep 30, 2022	10-Q	2022-11-10
Q2 2022	$34.1M	+$14M	+69.5%	Jun 30, 2022	10-Q	2022-08-08
Q1 2022	$37.1M			Mar 31, 2022	10-Q	2022-05-12
Q4 2021	$40.6M	+$38.8M	+2182%	Dec 31, 2021	10-K	2023-03-17
Q3 2021	$43.9M			Sep 30, 2021	10-Q	2021-11-15
Q2 2021	$20.1M			Jun 30, 2021	10-Q	2021-08-16
Q4 2020	$1.78M			Dec 31, 2020	10-K	2022-03-21

* An asterisk sign (*) next to the value indicates that the value is likely invalid.